Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-01

Clinical Trial Update: Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing IDP-126 Gel for acne vulgaris has completed with results posted in early 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IDP-126 Gel

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2024-02-01